User contributions for Davegupta
Jump to navigation
Jump to search
12 September 2018
- 00:3900:39, 12 September 2018 diff hist +23 m ACCORD →Criticisms
11 September 2018
- 23:2523:25, 11 September 2018 diff hist +1 m UKPDS 33 →Secondary Outcomes
12 August 2018
- 16:1816:18, 12 August 2018 diff hist +7 m VADT →Bottom Line current
- 16:1716:17, 12 August 2018 diff hist +37 VADT →Bottom Line
- 16:1616:16, 12 August 2018 diff hist +58 VADT →Criticisms
10 August 2018
- 15:3315:33, 10 August 2018 diff hist −233 CASTLE-AF →Criticisms current
25 June 2018
- 12:4812:48, 25 June 2018 diff hist +405 m Hokusai-VTE No edit summary
- 12:4812:48, 25 June 2018 diff hist −405 m Hokusai-VTE →Criticisms
8 April 2018
- 15:4215:42, 8 April 2018 diff hist 0 m HEAT →Subgroup Analysis
- 15:4115:41, 8 April 2018 diff hist +3 m HEAT →Outcomes
- 15:4015:40, 8 April 2018 diff hist +5 m HEAT →Bottom Line
- 15:3915:39, 8 April 2018 diff hist −1,150 HEAT added mortality data, corrected and synthesized outcome data, improved criticisms, improved major points
6 August 2017
- 02:1502:15, 6 August 2017 diff hist −2 PRORATA More accurate description of primary outcome, with attempt to remain neutral in tone. current Tag: visualeditor
10 July 2017
- 01:1701:17, 10 July 2017 diff hist +193 MODIFY I and II →Criticisms Tag: visualeditor
- 01:1401:14, 10 July 2017 diff hist +198 BEST →Criticisms Tag: visualeditor
18 April 2017
- 03:0603:06, 18 April 2017 diff hist +43 User:Davegupta →Melanoma current
- 03:0303:03, 18 April 2017 diff hist +144 User:Davegupta →Breast Cancer
- 03:0103:01, 18 April 2017 diff hist 0 m Canadian National Breast Screening Study No edit summary
- 03:0003:00, 18 April 2017 diff hist 0 m Canadian National Breast Screening Study →Criticisms
- 03:0003:00, 18 April 2017 diff hist +13 m Canadian National Breast Screening Study →Interventions
- 02:5902:59, 18 April 2017 diff hist +5,872 N Canadian National Breast Screening Study Annual mammography had no mortality benefit in women age 40-59
28 January 2017
- 21:5421:54, 28 January 2017 diff hist +113 MUSTT →Criticisms
- 21:5121:51, 28 January 2017 diff hist −111 MUSTT →Clinical Question
- 21:5021:50, 28 January 2017 diff hist −289 MUSTT →Bottom Line
- 21:4421:44, 28 January 2017 diff hist +131 MUSTT →Major Points
- 21:4021:40, 28 January 2017 diff hist −188 MUSTT →Criticisms
- 21:3621:36, 28 January 2017 diff hist +12 m MUSTT →Major Points
- 21:3621:36, 28 January 2017 diff hist −439 MUSTT →Major Points
- 20:4920:49, 28 January 2017 diff hist 0 EXCEL →Criticisms
- 20:4920:49, 28 January 2017 diff hist −420 EXCEL →Bottom Line
- 20:4520:45, 28 January 2017 diff hist −505 EXCEL →Major Points
- 20:2520:25, 28 January 2017 diff hist +88 EXCEL →Criticisms
- 20:1820:18, 28 January 2017 diff hist −20 EXCEL →Outcomes
- 19:5019:50, 28 January 2017 diff hist −146 AIRTRIP →Major Points
- 19:3819:38, 28 January 2017 diff hist −24 AIRTRIP →Interventions
- 19:3719:37, 28 January 2017 diff hist −428 AIRTRIP →Interventions
- 19:2719:27, 28 January 2017 diff hist −113 AIRTRIP →Criticisms
- 19:2619:26, 28 January 2017 diff hist +259 AIRTRIP →Criticisms
- 19:1619:16, 28 January 2017 diff hist −270 AIRTRIP →Bottom Line
- 02:3402:34, 28 January 2017 diff hist −273 m AIRTRIP →Criticisms Tag: visualeditor
27 January 2017
- 22:0022:00, 27 January 2017 diff hist −50 AIRTRIP →Criticisms Tag: visualeditor
11 November 2016
- 04:2004:20, 11 November 2016 diff hist +4 EORTC 18071 →Subgroup Analysis
- 04:1904:19, 11 November 2016 diff hist +4,480 N EORTC 18071 Ipilimumab substantially improves survival for patients with surgically resected Stage III melanoma
5 October 2016
- 23:3423:34, 5 October 2016 diff hist +182 AASK →Clinical Question Tag: visualeditor
26 September 2016
- 15:3615:36, 26 September 2016 diff hist +153 User:Davegupta →Oncology
- 15:3415:34, 26 September 2016 diff hist +1 m CLEOPATRA →Major Points
- 15:3315:33, 26 September 2016 diff hist 0 m CLEOPATRA →Adverse Events
- 15:3215:32, 26 September 2016 diff hist −10 m CLEOPATRA →Adverse Events
- 15:3115:31, 26 September 2016 diff hist +4,977 N CLEOPATRA Pertuzumab improves survival in HER2+ metastatic breast cancer
3 September 2016
- 16:2916:29, 3 September 2016 diff hist +171 KEYNOTE-006 →Outcomes